Rocuronium Bromide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Mylan Institutional, a Viatris Company with status Current. The shortage was first posted on 02/15/2023.
Shortage Details
- Status
- Current
- Company
- Mylan Institutional, a Viatris Company
- Package NDC
- 67457-228-05
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)
- Initial Posting
- 02/15/2023
- Revised Date